AZD4512
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AZD4512, covering 2026-04-03 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia [Phase 1, Phase 2]